NFKB1 and plasma cell myeloma: Similarly, treatment of human multiple myeloma cell line U266 with berberine resulted in Set9-mediated lysine methylation of the RelA subunit, which inhibited NF-κB nuclear translocation and miR-21 transcription, thereby inducing ROS generation and growth suppression [205].